TradeFlare's AI research teams analysed VIR on 5 market nights between June 24, 2026 and September 2, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 2, 2026 | BUY | $11.63 | $14.54 / $9.88 | -8.0% | -1.8% | The stock is near its 52-week high with strong technical and fundamental momentum, suggesting a short-to-medium term upward trend. |
| August 31, 2026 | BUY | $10.83 | $12.60 / $8.93 | +2.2% | -2.6% | The post-earnings drift signal suggests a multi-week trend. |
| August 28, 2026 | HOLD | $11.31 | — / — | +5.1% | -3.0% | Post-earnings drift signal from the scanner. |
| July 15, 2026 | BUY | $9.49 | — / — | -2.7% | -6.8% | Potential positive clinical trial data readouts for pipeline candidates. |
| June 24, 2026 | BUY | $10.16 | — / — | -3.9% | -6.1% | The stock is in a neutral market regime and exhibits mixed signals across teams, warranting a cautious approach. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.